Nuclear localization of the androgen receptor in prostate cancer circulating tumor cells from men who have failed androgen deprivation therapy.
Joshua M. Lang(University of Wisconsin–Madison), David J. Beebe(University of Wisconsin–Madison), Glenn Liu(University of Wisconsin Carbone Cancer Center), Jamie M. Sperger(University of Wisconsin–Madison), Lindsay N. Strotman(University of Wisconsin–Madison), Scott M. Berry(John Innes Centre), Benjamin P. Casavant(University of Wisconsin–Madison), Stephanie M. Thiede(University of Wisconsin Carbone Cancer Center)
Cited by 0
Related Papers
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
|New England Journal of Medicine|2015|2.8k
Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3
|Journal of Clinical Oncology|2016|1.6k
Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2019|1.6k
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial
|Journal of Clinical Oncology|2018|1.1k
Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors
|Proceedings of the National Academy of Sciences|2003|650